L
Lineage Cell Therapeutics Inc
F:BT3
Lineage Cell Therapeutics Inc
F:BT3
Price:
0.941
EUR
-2.99%
Market Closed
Market Cap:
€177.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
C
|
City Developments Ltd
SWB:CDE
|
SG |
|
A
|
Alaska Air Group Inc
SWB:ALK
|
US |
|
Polycab India Ltd
NSE:POLYCAB
|
IN |
|
P
|
Providence Resources PLC
F:PZQA
|
IE |
|
C
|
Credit Agricole SA
XHAM:XCA
|
FR |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
DUS:BOY
|
ES |
|
S
|
Smartone Telecommunications Holdings Ltd
XMUN:SMA
|
HK |
|
A
|
Atkore Inc
F:AOA
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
F:MUVB
|
DE |
|
SFC Energy AG
OTC:SSMFF
|
DE |
|
M
|
MorphoSys AG
DUS:MOR
|
DE |
|
A
|
Adaro Energy Indonesia TBK PT
OTC:PADEF
|
ID |
|
CH Robinson Worldwide Inc
NASDAQ:CHRW
|
US |
|
Condor Energies Inc
TSX:CDR
|
CA |
DCF Valuation
is not available for Lineage Cell Therapeutics Inc
is not available for Lineage Cell Therapeutics Inc
BT3's DCF value cannot be reliably calculated.
Switch to
Continue BT3 Research
Other Lineage Cell Therapeutics Inc listings:
Discover More
